Lung Ultrasound Evaluation After Different Surfactant Treatments in Preterm Infants Born Before 32 Weeks
Led by Konya City Hospital · Updated on 2026-07-09
68
Participants Needed
1
Research Sites
21 weeks
Total Duration
AI-Summary
What This Trial Is About
This research investigates how different methods of surfactant delivery affect lung ultrasound results in preterm infants diagnosed with respiratory distress syndrome RDS. The study focuses on babies born before 32 weeks gestation who require surfactant therapy, aiming to compare lung ultrasound scores over time based on the surfactant administration technique used. Lung ultrasound is an important tool in diagnosing and managing RDS, offering a quick, bedside alternative to chest X-rays.
Two surfactant administration methods are assessed one involves intubating the infant, delivering surfactant, then extubating back to nasal support ENSURE method, and the other delivers surfactant via a thin catheter while the infant remains on nasal respiratory support LISA method. Both methods are commonly used in neonatal intensive care units, and the study seeks to understand differences in lung ultrasound findings after treatment by performing serial ultrasounds at multiple time points within six hours following surfactant administration.
Participants will undergo seven lung ultrasound exams at 5, 10, 20, 30 minutes, and 1, 2, and 6 hours after surfactant treatment. Each exam scores lung regions to measure lung status. The study collects clinical and demographic data, oxygen needs, and saturation levels without changing routine treatment or performing invasive procedures. The goal is to evaluate changes in lung ultrasound scores related to the surfactant delivery method to inform future care approaches.
CONDITIONS
Brief Title
Evaluation of Serial Lung Ultrasound Data After Surfactant Treatments Applied With Different Methods in Preterm Babies
Research Team
M
MELEK BUYUKEREN
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Infants diagnosed with respiratory distress syndrome requiring surfactant therapy
You will not qualify if you...
Families do not provide consent
Infants with syndromic appearance
Infants with congenital heart disease
Preterm infants born after 32 weeks of gestation
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surfactant Treatment and Ultrasound Monitoring
Duration - 6 hours
Participants receive surfactant via one of two methods determined by their doctor. Seven lung ultrasounds are performed at specific times after treatment to track lung changes.
7 ultrasound evaluations at 5, 10, 20, 30 minutes and 1, 2, 6 hours post-treatment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Similar Trials
Ultrasound-Guided Surfactant Therapy Compared to Standard Guidelines for Premature Infants with Respiratory Distress Syndrome
European Management Platform for Childhood Interstitial Lung Diseases including an International Register and Biobank to Improve Diagnosis and Treatment
Lung Ultrasound Evaluation After Different Surfactant Treatments in Preterm Infants Born Before 32 Weeks
Comparing Surfactant Delivery by Thin Catheter Versus Endotracheal Tube in Preterm Babies With Respiratory Distress Syndrome Using Lung Ultrasound
PrePAP Trial Comparing Breathing Support Methods at Extubation in Very Preterm Infants
Predicting Respiratory Distress Syndrome and Need for Extended Breathing Support in Newborns Born at 32 Weeks or Later in a Lower-Level NICU
Study of Early Surfactant Treatment Using a Minimally Invasive Method in Preterm Infants Under 30 Weeks Gestation to Improve Respiratory Outcomes
Using Lung Ultrasound Score to Guide Minimally Invasive Surfactant Treatment in Moderate to Late Preterm Infants with Respiratory Distress Syndrome
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial.
Prince Pareek, Sujata Deshpande, Pradeep Suryawanshi...
International evidence-based guidelines on Point of Care Ultrasound (POCUS) for critically ill neonates and children issued by the POCUS Working Group of the European Society of Paediatric and Neonatal Intensive Care (ESPNIC).